13F filer · CIK 19617 ↗
Jpmorgan Chase & Co
You are looking at Q4 2019. See the latest, Q2 2026 →
Reported value
$536.28B
+6.8% on the quarter before
Positions
5,677
437 new · 554 sold out
Top 10
16.9%
of the value
Est. gain
+$32.93B
on stocks held all quarter
Est. return
+7.9%
on those stocks since Q3 2019
Positions as of Dec 31, 2019, from Jpmorgan Chase & Co's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 27% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2019. Striped tiles are options.
Largest buys
Since Q3 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SPDR S&P 500 ETF TrPUT~$5.38BAdded · 0.9% → 1.9%+16,706,500 underlying
- ApplePUT~$2.69BAdded · 0.1% → 0.6%+9,176,700 underlying
- Truist Finl Corp~$1.73BNew · 0.0% → 0.3%+30,783,949 shares
- Bristol Myers Squibb Co~$1.02BAdded · 0.4% → 0.6%+15,871,346 shares
- Ishares 20 Year Treasury Bo~$1.02BAdded · 0.2% → 0.4%+7,499,447 shares
- Tesla~$911.9MAdded · 0.0% → 0.2%+2,179,933 shares
- SPDR S&P 500 ETF TrCALL~$872.8MAdded · 0.4% → 0.5%+2,711,700 underlying
- Johnson & Johnson~$842.4MAdded · 0.5% → 0.7%+5,774,899 shares
- Texas Instruments~$831.4MAdded · 0.6% → 0.7%+6,480,342 shares
- Ishares TrCALL~$734.3MAdded · 0.0% → 0.1%+8,350,000 underlying
Largest sells
Since Q3 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Pfizer Inc~$1.50BCut · 0.6% → 0.4%−38,170,142 shares
- Ishares Russell 2000 ETF~$1.27BCut · 0.4% → 0.1%−7,676,399 shares
- Microsoft~$1.05BCut · 2.5% → 2.5%−6,671,061 shares
- Suntrust Bks Inc~$987.3MSold out · 0.2% → 0.0%−14,350,560 shares
- Celgene Corp~$928.9MSold out · 0.2% → 0.0%−9,354,501 shares
- SPDR S&P 500 ETF Trust~$913.0MCut · 4.5% → 4.4%−2,836,610 shares
- Netflix~$703.8MCut · 0.4% → 0.3%−2,175,080 shares
- Bb&T Corp~$692.9MSold out · 0.1% → 0.0%−12,982,992 shares
- Ishares TrPUT~$672.2MCut · 0.4% → 0.3%−6,153,900 underlying
- SPDR S&P Biotech ETF~$620.1MCut · 0.1% → 0.0%−6,519,760 shares
Holdings
As of Dec 31, 2019. Changes are in shares against Sep 30, 2019, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPDR S&P 500 ETF TrustFUND · shares −3.7% · price +8.5% | 4.4% | $23.83B | +$1.86B | ||||||||
| MicrosoftCOMMON · shares −7.4% · price +13.4% | 2.5% | $13.15B | +$1.56B | ||||||||
| SPDR S&P 500 ETF TrPUTOPTION · shares +106% | 1.9% | $10.45B | — | ||||||||
| AppleCOMMON · shares −3.5% · price +31.1% | 1.6% | $8.84B | +$2.10B | ||||||||
| AmazonCOMMON · shares −2.8% · price +6.4% | 1.4% | $7.27B | +$440.7M | ||||||||
| Vanguard Total Intl Bond ETFFUND · shares +7.5% · price −3.8% | 1.2% | $6.55B | −$242.4M | ||||||||
| Ishares Msci Eafe ETFFUND · shares −0.8% · price +6.5% | 1.1% | $5.67B | +$345.6M | ||||||||
| AlibabaADR · shares −4.0% · price +26.8% | 0.96% | $5.13B | +$1.08B | ||||||||
| AlphabetCOMMON · shares +0.1% · price +9.7% | 0.92% | $4.93B | +$434.2M | ||||||||
| Unitedhealth Group IncCOMMON · shares +6.3% · price +35.3% | 0.90% | $4.84B | +$1.19B | ||||||||
| Bank Amer CorpCOMMON · shares −1.9% · price +20.7% | 0.80% | $4.29B | +$736.4M | ||||||||
| AlphabetCOMMON · shares −3.1% · price +9.7% | 0.77% | $4.15B | +$366.0M | ||||||||
| TSMCADR · shares −1.7% · price +25.0% | 0.77% | $4.11B | +$822.9M | ||||||||
| Ishares 7-10 Year Treasury BFUND · shares +4.3% · price −2.0% | 0.76% | $4.10B | −$80.2M | ||||||||
| MastercardCOMMON · shares −3.7% · price +9.9% | 0.74% | $3.99B | +$361.5M | ||||||||
| Chevron Corp NewCOMMON · shares +2.2% · price +1.6% | 0.73% | $3.90B | +$60.5M | ||||||||
| Texas InstrumentsCOMMON · shares +28% · price −0.7% | 0.70% | $3.78B | −$21.8M | ||||||||
| Jpmorgan Betabuilders CanadaFUND · shares −0.03% · price +4.0% | 0.70% | $3.75B | +$142.8M | ||||||||
| Jpmorgan Betabuilders Europe ETFFUND · shares −1.5% · price +8.8% | 0.69% | $3.68B | +$297.4M | ||||||||
| Jpmorgan Betabuilders Japan ETFFUND · shares +0.5% · price +3.4% | 0.67% | $3.62B | +$117.3M | ||||||||
| Johnson & JohnsonCOMMON · shares +30% · price +12.7% | 0.67% | $3.61B | +$313.4M | ||||||||
| Ishares Core Msci Eafe ETFFUND · shares +6.4% · price +6.8% | 0.65% | $3.50B | +$210.0M | ||||||||
| Coca Cola CoCOMMON · shares −1.2% · price +1.7% | 0.65% | $3.46B | +$56.9M | ||||||||
| Bristol Myers Squibb CoCOMMON · shares +45% · price +26.6% | 0.62% | $3.30B | +$480.1M | ||||||||
| ApplePUTOPTION · shares +476% | 0.61% | $3.26B | — | ||||||||
| Total · 5,677 positions | 100% | $536.28B | +$32.93B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2019 to Q4 2019: 4,236 stocks held throughout, up $32.93B (+7.9%).
- Apple+$2.10B+31%
- SPDR S&P 500 ETF Trust+$1.86B+8%
- Microsoft+$1.56B+13%
- Unitedhealth Group Inc+$1.19B+35%
- Alibaba+$1.08B+27%
- Ribbon Communications Inc−$136.9M−47%
- Mcdonalds Corp−$148.8M−8%
- Home Depot Inc−$200.5M−6%
- Vanguard Total Intl Bond ETF−$242.4M−4%
- Ventas Inc−$254.9M−21%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 17 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $1.81T+16% | SEC ↗ |
| Q1 2026 | May 13, 2026 (amended) | $1.56T−2% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $1.59T−52% | SEC ↗ |
| Q3 2025 | Nov 7, 2025 (amended) | $3.34T+118% | SEC ↗ |
| Q2 2025 | Aug 12, 2025 | $1.53T+12% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $1.37T+2% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 | $1.34T−49% | SEC ↗ |
| Q3 2024 | Nov 8, 2024 (amended) | $2.63T+8% | SEC ↗ |
| Q2 2024 | Aug 12, 2024 (amended) | $2.44T+3% | SEC ↗ |
| Q1 2024 | May 10, 2024 (amended) | $2.37T+14% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $2.08T+130% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $906.36B−2% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $920.27B+12% | SEC ↗ |
| Q1 2023 | May 18, 2023 (amended) | $820.88B+8% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $758.55B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $696.38B−3% | SEC ↗ |
| Q2 2022 | Aug 11, 2022 | $717.86B−14% | SEC ↗ |
| Q1 2022 | May 11, 2022 | $830.28B−4% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 (amended) | $865.90B+7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $808.68B−4% | SEC ↗ |
| Q2 2021 | Aug 12, 2021 | $838.21B+12% | SEC ↗ |
| Q1 2021 | May 12, 2021 | $749.21B+10% | SEC ↗ |
| Q4 2020 | Feb 19, 2021 (amended) | $680.63B+14% | SEC ↗ |
| Q3 2020 | Nov 12, 2020 (amended) | $595.09B+15% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $518.17B+22% | SEC ↗ |
| Q1 2020 | May 12, 2020 | $425.90B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $536.28B+7% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $502.15B−2% | SEC ↗ |
| Q2 2019 | Aug 7, 2019 | $511.43B+4% | SEC ↗ |
| Q1 2019 | May 7, 2019 | $489.55B+13% | SEC ↗ |
| Q4 2018 | Feb 11, 2019 | $432.49B−17% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 (amended) | $522.20B+7% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $486.35B+4% | SEC ↗ |
| Q1 2018 | May 10, 2018 | $466.55B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $474.64B+5% | SEC ↗ |
| Q3 2017 | Nov 9, 2017 | $453.26B+4% | SEC ↗ |
| Q2 2017 | Aug 9, 2017 | $437.53B−0% | SEC ↗ |
| Q1 2017 | May 10, 2017 | $437.58B+5% | SEC ↗ |
| Q4 2016 | Feb 6, 2017 | $416.17B+2% | SEC ↗ |
| Q3 2016 | Nov 4, 2016 | $406.33B+1% | SEC ↗ |
| Q2 2016 | Aug 8, 2016 | $401.04B+3% | SEC ↗ |
| Q1 2016 | May 10, 2016 | $390.67B | SEC ↗ |